Osteopontin promoter polymorphism is associated with increased carotid intima-media thickness

被引:23
作者
de las Fuentes, Lisa [1 ]
Gu, C. Charles [2 ]
Mathews, Santhosh J. [1 ]
Reagan, Joann L. [1 ]
Ruthmann, Nicholas P. [1 ]
Waggoner, Alan D. [1 ]
Lai, Chung-Fang [3 ]
Towler, Dwight A. [3 ]
Davila-Roman, Victor G. [1 ]
机构
[1] Washington Univ, Sch Med, Div Cardiovasc, Cardiovas Imaging & Clin Res Core Lab, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA
关键词
metabolic syndrome; carotid arteries; arteriosclerosis; genetics; growth substances;
D O I
10.1016/j.echo.2008.02.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Osteopontin ( OPN)-transgenic mice exhibit increased carotid artery intima-media thickness ( CIMT), smooth muscle cell proliferation, and atheroma formation. Methods: An association of the human T-66G promoter variant with CIMT was examined in Caucasian adults grouped according to metabolic syndrome criteria: present ( + MetS; n = 70) or absent ( + MetS; n = 70). Results: The G-allele frequency was 22%. For the entire cohort, the G group ( TG and GG) was associated with significantly lower age-adjusted and gender-adjusted CIMT compared with the TT group ( P =.008); similar analysis by metabolic syndrome group found a significant difference only in the - MetS group ( P =.018). Stepwise multivariate regression showed that after age and waist circumference, the T-66G variant was the next most predictive of CIMT ( P =.007). These data suggest that in a normoglycemic environment, human vascular OPN gene expression contributes to arterial structure, an effect diminished in dysmetabolic states. Conclusion: Humans with the OPN - 66 TT genotype, particularly those without metabolic syndrome, exhibit thicker CIMT.
引用
收藏
页码:954 / 960
页数:7
相关论文
共 54 条
[11]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[12]   Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly [J].
Galis, ZS ;
Khatri, JJ .
CIRCULATION RESEARCH, 2002, 90 (03) :251-262
[13]   OSTEOPONTIN IS ELEVATED DURING NEOINTIMA FORMATION IN RAT ARTERIES AND IS A NOVEL COMPONENT OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GIACHELLI, CM ;
BAE, N ;
ALMEIDA, M ;
DENHARDT, DT ;
ALPERS, CE ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1686-1696
[14]   Osteopontin: a versatile regulator of inflammation and biomineralization [J].
Giachelli, CM ;
Steitz, S .
MATRIX BIOLOGY, 2000, 19 (07) :615-622
[15]   Polymorphisms in the osteopontin promoter affect its transcriptional activity [J].
Giacopelli, F ;
Marciano, R ;
Pistorio, A ;
Catarsi, P ;
Canini, S ;
Karsenty, G ;
Ravazzolo, R .
PHYSIOLOGICAL GENOMICS, 2004, 20 (01) :87-96
[16]   Association between osteopontin and human abdominal aortic aneurysm [J].
Golledge, Jonathan ;
Muller, Juanita ;
Shephard, Neil ;
Clancy, Paula ;
Smallwood, Linda ;
Moran, Corey ;
Dear, Anthony E. ;
Palmer, Lyle J. ;
Norman, Paul E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) :655-660
[17]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752
[18]   Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease - The San Antonio Heart Study [J].
Hanley, AJG ;
Williams, K ;
Stern, MP ;
Haffner, SM .
DIABETES CARE, 2002, 25 (07) :1177-1184
[19]   Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank -: An integrated model of the pathogenesis of mineralization disorders [J].
Harmey, D ;
Hessle, L ;
Narisawa, S ;
Johnson, KA ;
Terkeltaub, R ;
Millán, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1199-1209
[20]   The role of carotid arterial intima-media thickness in predicting clinical coronary events [J].
Hodis, HN ;
Mack, WJ ;
LaBree, L ;
Selzer, RH ;
Liu, CR ;
Liu, CH ;
Azen, SP .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (04) :262-+